Multicenter Evaluation of Diagnostic Circulating Biomarkers to Detect Sight-Threatening Diabetic Retinopathy-Reference-Cited by-同舟云学术

Multicenter Evaluation of Diagnostic Circulating Biomarkers to Detect Sight-Threatening Diabetic Retinopathy

Published:2022-06-01 Issue:6 Volume:140 Page:587
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Gurudas Sarega¹,Frudd Karen¹,Maheshwari Jayapal Jeya²,Revathy Yeddula Rebecca³,Sivaprasad Sobha¹⁴,Ramanathan Shruthi Mahalakshmi²,Pooleeswaran Vignesh²,Prevost A. Toby⁵,Karatsai Eleni⁴,Halim Sandra¹,Chandra Shruti¹⁴,Nderitu Paul⁶,Conroy Dolores¹,Krishnakumar Subramanian³,Parameswaran Sowmya³,Dharmalingam Kuppamuthu²,Ramasamy Kim⁷,Raman Rajiv³,Jones Colin⁸,Eleftheriadis Haralabos⁶,Greenwood John¹,Turowski Patric¹

Affiliation:

1. Institute of Ophthalmology, University College London, London, United Kingdom

2. Aravind Medical Research Foundation, Proteomics Department, No.1 Anna Nagar, Madurai, India

3. Vision Research Foundation, Chennai, India

4. National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital London NHS Foundation Trust, London, United Kingdom

5. Nightingale-Saunders Clinical Trials and Epidemiology Unit, King’s College London, London, United Kingdom

6. Ophthalmology Department, King’s College University Hospital Trust, London, United Kingdom

7. Aravind Eye Hospital, Madurai, India

8. Norfolk and Norwich University Hospitals NHS Trust, Norwich, United Kingdom

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Link

https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2791892/jamaophthalmology_gurudas_2022_oi_220023_1654722536.97257.pdf

Reference24 articles.

1. A review of advancements and evidence gaps in diabetic retinopathy screening models.;Pearce;Clin Ophthalmol,2020